クロフィブリド
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/13 23:42:23」(JST)
[Wiki en表示]
Clofibride
|
Systematic (IUPAC) name |
3-(dimethylcarbamoyl)propyl 2-(4-chlorophenoxy)-2-methylpropanoate |
Clinical data |
Legal status |
? |
Pharmacokinetic data |
Metabolism |
Hydrolyzed to clofibric acid; hepatic glucuronidation |
Half-life |
12 hours (clofibric acid) |
Excretion |
Renal (mostly) and fecal |
Identifiers |
CAS number |
26717-47-5 |
ATC code |
C10AB10 |
PubChem |
CID 160134 |
ChemSpider |
140758 Y |
UNII |
0S9SLS3L93 Y |
KEGG |
D07188 Y |
Chemical data |
Formula |
C16H22ClNO4 |
Mol. mass |
327.803 g/mol |
SMILES
- Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1
|
InChI
-
InChI=1S/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3 Y
Key:CXQGFLBVUNUQIA-UHFFFAOYSA-N Y
|
Y (what is this?) (verify) |
Clofibride is a fibrate.
Lipid modifying agents (C10)
|
|
GI tract |
Cholesterol absorption inhibitors, NPC1L1
|
|
|
Bile acid sequestrants/resins (LDL)
|
- Cholestyramine
- Colestipol
- Colestilan
- Colextran
- Colesevelam
|
|
|
Liver |
Statins (HMG-CoA reductase, LDL)
|
- Simvastatin#
- Atorvastatin
- Fluvastatin
- Lovastatin
- Mevastatin
- Pitavastatin
- Pravastatin
- Rosuvastatin
- Cerivastatin‡
|
|
Niacin and derivatives (HDL and LDL)
|
- Niceritrol
- Niacin
- Nicofuranose
- Aluminium nicotinate
- Nicotinyl alcohol
- Acipimox
|
|
MTTP inhibitors (VLDL)
|
- Dirlotapide
- Lomitapide
- Mitratapide
|
|
|
Blood vessels |
Fibrates (PPAR)
|
- Clofibrate‡
- Bezafibrate
- Aluminium clofibrate
- Gemfibrozil
- Fenofibrate
- Simfibrate
- Ronifibrate
- Ciprofibrate
- Etofibrate
- Clofibride
- Clinofibrate
|
|
CETP inhibitors (HDL)
|
- Anacetrapib†
- Dalcetrapib§
- Evacetrapib§
- Torcetrapib†
|
|
|
Combinations |
- Niacin/lovastatin
- Niacin/simvastatin
- Ezetimibe/simvastatin
- Ezetimibe/atorvastatin
- Niacin/laropiprant
|
|
Other |
- Dextrothyroxine‡
- Probucol
- Tiadenol
- Benfluorex
- Meglutol
- Omega-3-triglycerides
- Magnesium pyridoxal 5-phosphate glutamate
- Policosanol
- Lapaquistat§
- Mipomersen
- Alipogene tiparvovec
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
English Journal
- An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride.
- Magalhaes NS1, Fessi H, Puisieux F, Benita S, Seiller M.
- Journal of microencapsulation.J Microencapsul.1995 Mar-Apr;12(2):195-205.
- Polylactic acid nanocapsules of clofibride containing soybean oil (SO) or medium-chain triglycerides (MCT) as the oil core were prepared. The in-vitro drug release kinetic profiles were determined and compared to those of a clofibride submicron emulsion using two different kinetic techniques: the bu
- PMID 7629662
- [Basic principles of drug therapy of hyperlipoproteinemia].
- Romics L.
- Orvosi hetilap.Orv Hetil.1988 Nov 6;129(45):2391-9.
- PMID 3054710
- [Effect of clofibride on the lipolysis of perirenal adipose tissue in hyperlipemic rabbits].
- Elsair J, Marquie G, Tabet Aoul M, Dahmani Y, Tabet Aoul FS, Dufour P, Khelfat K, Iklef F, Ghouini A.
- Comptes rendus des seances de la Societe de biologie et de ses filiales.C R Seances Soc Biol Fil.1982;176(2):146-50.
- In hyperlipaemic rabbits (fat supply), perirenal adipose tissue lipolysis does not vary with one in vitro clofibride dose. After a 16 days pretreatment, one in vitro clofibride dose reduces the basal lipolysis and the lipolytic action of synacthene, and increases the antilipolytic effect of insulin.
- PMID 6212099
Related Links
- Clofibride | C16H22ClNO4 | CID 160134 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. ... A chemical ...
- BPR regulation aims to improve the functioning of the biocidal products market in the EU, while ensuring a high level of protection for humans and the environment. Understanding BPR Legislation Upcoming deadlines Active ...
★リンクテーブル★
[★]
- 英
- clofibride
- 関
- 高脂血症治療薬
参考
- http://www.genome.jp/dbget-bin/www_bget?dr_ja:D07188